Form 4: Lemaitre Vascular Director Acquires Shares via Vesting
Insider Transaction Report
Lemaitre Vascular Director Joseph P. Pellegrino JR acquired 3 shares of common stock through the release of dividend equivalent rights.
Summary
- Joseph P. Pellegrino JR, a Director at Lemaitre Vascular Inc. (LMAT), acquired 3 shares of common stock.
- The acquisition occurred on December 6, 2025, at a price of $0 per share, resulting from the release of dividend equivalent rights.
- Following this transaction, Mr. Pellegrino directly beneficially owns 9,569 shares of common stock.
- Several dividend equivalent rights (DERs) were acquired on December 4, 2025, and December 6, 2025, which are the economic equivalent of common stock.
- These DERs accrued on various restricted stock unit (RSU) and performance share unit (PSU) awards granted between December 2021 and December 2024, vesting proportionately with the underlying awards.
- A total of 3 dividend equivalent rights were released on December 6, 2025, corresponding to the common stock acquisition.
Sentiment
Score: 6
Explanation: The filing reports a routine insider transaction related to the vesting of equity awards, which is a neutral to slightly positive event as it increases direct insider ownership, albeit by a small amount.
Positives
- Director Joseph P. Pellegrino JR increased his direct beneficial ownership of Lemaitre Vascular common stock by 3 shares.
- The acquisition stems from the vesting and release of previously granted dividend equivalent rights, indicating a planned increase in insider holdings.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders may view the increase in a director's direct ownership, even if small and routine, as a minor positive signal of alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 12/11/2021 | Grant date for a restricted stock unit award on which dividend equivalent rights accrued. |
| 12/12/2022 | Grant date for a restricted stock unit award and a performance share unit award on which dividend equivalent rights accrued. |
| 12/08/2023 | Grant date for a restricted stock unit award and a performance share unit award on which dividend equivalent rights accrued. |
| 12/06/2024 | Grant date for a restricted stock unit award on which dividend equivalent rights accrued and were released. |
| 12/04/2025 | Transaction date for the acquisition of multiple dividend equivalent rights. |
| 12/06/2025 | Transaction date for the acquisition of 3 shares of common stock and the release of 3 dividend equivalent rights. |
| 12/08/2025 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed and filed. |
Recommendation
holdThis Form 4 details a routine, pre-planned insider transaction involving a small number of shares acquired through vesting. It does not provide new material information that would significantly alter the company's fundamental valuation or strategic outlook, thus warranting a 'hold' recommendation based solely on this filing.
Keywords
LEMAITRE VASCULAR, LMAT, Form 4, insider transaction, stock acquisition, director ownership, beneficial ownership, dividend equivalent rights, restricted stock units, performance share units, vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.